Ms. Kim Rivers reports

TRULIEVE ANNOUNCES APPLICATIONS FILED FOR DEA REGISTRATION OF STATE LICENSED MEDICAL MARIJUANA BUSINESSES

Trulieve Cannabis Corp. has filed applications with the U.S. Drug Enforcement Administration to register certain state-licensed medical marijuana operations pursuant to the expedited registration pathway established by the recent rescheduling of medical marijuana to Schedule III under the Controlled Substances Act.

"DEA registration for our medical business marks a historic step forward for Trulieve and the patients we serve," said Trulieve chief executive officer Kim Rivers. "With over 200 dispensaries serving only medical patients, Trulieve is uniquely positioned to set the bar as a responsible operator in U.S. cannabis."

Following the reclassification of medical marijuana to Schedule III, the DEA established an expedited registration process for eligible state-licensed medical marijuana operators. For operators that apply within 60 days, licensure to manufacture, distribute and dispense Schedule III medical marijuana products is deemed approved unless otherwise notified.

About Trulieve Cannabis Corp.

Trulieve is an industry-leading, vertically integrated cannabis company and multistate operator in the United States, with established hubs in the northeast, southeast and southwest, anchored by cornerstone markets in Arizona, Florida, Ohio and Pennsylvania. Driven by a core mission to expand access to cannabis, Trulieve serves customers with innovative, high-quality branded products and exceptional experiences. With scaled operations in attractive markets and targeted expansion through its hub strategy, Trulieve is poised for accelerated growth. Trulieve is listed on the Canadian Securities Exchange under the symbol TRUL and trades on the OTCQX market under the symbol TCNNF.